Ahead of Earnings: Tilray Brands, Accolade, and AngioDynamics in the Spotlight
- September 30th, 2023
- 693 views
Some of the companies expected to report financial results on Wednesday, October 4, are:
Tilray Brands, Inc. (Nasdaq: TLRY), a company in the cannabis industry, is scheduled to release its first-quarter fiscal 2024 financial results before the market opens.
Analysts are forecasting a loss of $0.05 per share on revenue of $174 million.
On Friday, $TLRY closed at $2.39, up $0.04 (+1.70%).
Accolade, Inc. (Nasdaq: ACCD), a provider of personalized healthcare solutions, will unveil its fiscal second-quarter 2024 financial results after the market closes.
The consensus estimate points to a loss of $0.54 per share, accompanied by revenue reaching $94.09 million.
$ACCD closed at $10.58 on Friday, reflecting a decrease of $0.18 (-1.67%).
AngioDynamics, Inc. (Nasdaq: ANGO), a medical device company, is set to report financial results for the first quarter of fiscal year 2024 before the market opens.
Analysts expect a loss of $0.13 per share on revenue of $77.69 million.
On Friday, $ANGO closed at $7.31, down $0.01 (-0.14%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
DOT, DoW, DHS Join Forces to Protect Southern Border Airspace
October 16th, 2026FTC Sues Ticket Broker Over Unlawful Tactics Used to Buy Millions of Tickets to Popular Live Events
October 15th, 2026October 15th, 2026FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
October 14th, 2026U.S. Treasury Announces Record Enforcement Actions Against Bank of America
October 14th, 2026
Member Login